Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Maalox
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Maalox 175mg/200mg/5ml oral suspension
0101010G0BBAHAG
|
Maalox | Co-magaldrox (Magnesium/aluminium hydroxide) | Gastro-Intestinal System | 738 |
|
Maalox oral suspension
0101010G0BBABAB
|
Maalox | Co-magaldrox (Magnesium/aluminium hydroxide) | Gastro-Intestinal System | 6 |
|
Maalox TC oral suspension
0101010G0BBACAC
|
Maalox | Co-magaldrox (Magnesium/aluminium hydroxide) | Gastro-Intestinal System | No data available |
|
Maalox TC tablets
0101010G0BBADAD
|
Maalox | Co-magaldrox (Magnesium/aluminium hydroxide) | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.